Brain Development: The dangers of rubella virus
The rubella virus can interfere with fetal brain development by infecting immune cells called microglia during pregnancy.
- Laboratory of Molecular Regulation of Neurogenesis, GIGA‐Stem Cells and GIGA-Neurosciences, Interdisciplinary Cluster for Applied Genoproteomics (GIGA‐R), University of Liège, Belgium
- WELBIO department, WEL Research Institute, Belgium
Some pathogens can be extremely harmfull during pregnancy as they can cross the placenta, infect the fetus, and go on to cause congenital birth defects, miscarriages and stillbirths (Pereira, 2018). The rubella virus, for example, can cause a range of congenital brain defects, and it is also associated with a higher risk of babies developing congenital rubella syndrome, a complex condition associated with developmental delays, cardiac anomalies, hearing impairment and eye abnormalities (Bardeletti et al., 1975; Lazar et al., 2016; Toizumi et al., 2017). These viruses and other pathogens are collectively referred to as TORCH pathogens, which is short for toxoplasmosis (which is caused by a parasite), other pathogens (such as syphilis, varicella, mumps, parvovirus B19 and HIV), rubella, cytomegalovirus, and herpes simplex virus.
Despite the threat they pose to public health, the mechanisms by which TORCH pathogens affect brain development remain poorly understood. Now, in eLife, Tomasz Nowakowski, Joseph DeRisi and colleagues at the University of California San Francisco – including Galina Popova and Hanna Retallack as joint first authors – report new insights into the infection of brain cells by the rubella virus (Popova et al., 2023).
The researchers combined analyses of live human fetal brain slices that were maintained in the laboratory and two-dimensional cell cultures to study how the rubella virus affects brain cells. This revealed that the virus predominantly infects immune cells called microglia, which patrol and scavenge the central nervous system for damaged cells and pathogens. Microglia also have an important role in protecting the brain during development.
The experiments revealed that the rubella virus can only infect microglia when a variety of other brain cells are present. This is likely due to some yet-to-be-identified diffusible factors released by the other brain cells, which could render microglia susceptible to infection. However, the microglia do not need to make direct contact with these other cells in order to get infected.
Microglia play a crucial role in the antiviral immune response by releasing inflammatory cytokines, such as interferons (Sala and Kuka, 2020). Popova et al. found that infection with the rubella virus leads to an excessive interferon response by neighbouring neuronal cells, and this could have a deleterious effect on brain development. This is consistent with previous research, which showed that prenatal infection with rubella and HIV can trigger the overproduction of interferons, leading to prolonged inflammation that may contribute to the atypical development of the fetus (Crow et al., 2003). Certain inflammatory disorders, such as systemic lupus erythematosus and Aicardi-Goutières syndrome, are also characterized by an increased interferon response, and it is possible that some TORCH infections (in particular HIV and Rubella) share certain phenotypic similarities with these conditions.
As with many other TORCH pathogens, the fetus is most vulnerable to the rubella virus during the first trimester of pregnancy, due to the lack of immune defense in the developing fetus. Microglia populate the brain about a month into pregnancy, and the blood-brain barrier in the fetal brain only starts to be functional about two months into pregnancy (Menassa and Gomez-Nicola, 2018; Goasdoué et al., 2017). The brain is therefore extremely vulnerable to viruses during the first trimester of pregnancy, which coincides with a higher risk of developing severe developmental disorders.
The study of Popova et al. highlights the importance of using human cell-based models to better understand the pathophysiological mechanisms of congenital rubella syndrome. It remains to be seen why and how the rubella virus specifically attacks microglia, and what its molecular targets are. Identifying the molecular cues released by other brain cells, which potentially increase infection, will be necessary to eventually develop therapies against congenital rubella syndrome.
Figure 1
The effect of rubella virus on the brain development.
Rubella viruses (orange circles) target immune cells, called microglia (red), in the brain of the fetus. Popova et al. show that other neighbouring brain cells (pink, green and blue) must be present for infection to take place: it is thought that infection relies on diffusible factors released by these cells. Infection causes the release of large amounts of a signaling protein, called interferon (IFN; purple), which can damage the developing brain.
References
-
Morphology, biochemical analysis and neuraminidase activity of rubella virusArchives of Virology 49:175–186.https://doi.org/10.1007/BF01317536
-
Microglial dynamics during human brain developmentFrontiers in Immunology 9:1014.https://doi.org/10.3389/fimmu.2018.01014
-
Congenital viral infection: traversing the uterine-placental interfaceAnnual Review of Virology 5:273–299.https://doi.org/10.1146/annurev-virology-092917-043236
Article and author information
Author details
Ekaterina Epifanova
Publication history
Copyright
© 2023, Epifanova and Nguyen
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,313
- views
-
- 82
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Brain Development: The dangers of rubella virus
eLife 12:e89265.
https://doi.org/10.7554/eLife.89265
Further reading
-
- Medicine
- Neuroscience
Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3-induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive DRG neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying neuronal mechanisms of pain inhibition induced by FLO and HC-HA/PTX3.
-
- Computational and Systems Biology
- Neuroscience
Hypothalamic kisspeptin (Kiss1) neurons are vital for pubertal development and reproduction. Arcuate nucleus Kiss1 (Kiss1ARH) neurons are responsible for the pulsatile release of gonadotropin-releasing hormone (GnRH). In females, the behavior of Kiss1ARH neurons, expressing Kiss1, neurokinin B (NKB), and dynorphin (Dyn), varies throughout the ovarian cycle. Studies indicate that 17β-estradiol (E2) reduces peptide expression but increases Slc17a6 (Vglut2) mRNA and glutamate neurotransmission in these neurons, suggesting a shift from peptidergic to glutamatergic signaling. To investigate this shift, we combined transcriptomics, electrophysiology, and mathematical modeling. Our results demonstrate that E2 treatment upregulates the mRNA expression of voltage-activated calcium channels, elevating the whole-cell calcium current that contributes to high-frequency burst firing. Additionally, E2 treatment decreased the mRNA levels of canonical transient receptor potential (TPRC) 5 and G protein-coupled K+ (GIRK) channels. When Trpc5 channels in Kiss1ARH neurons were deleted using CRISPR/SaCas9, the slow excitatory postsynaptic potential was eliminated. Our data enabled us to formulate a biophysically realistic mathematical model of Kiss1ARH neurons, suggesting that E2 modifies ionic conductances in these neurons, enabling the transition from high-frequency synchronous firing through NKB-driven activation of TRPC5 channels to a short bursting mode facilitating glutamate release. In a low E2 milieu, synchronous firing of Kiss1ARH neurons drives pulsatile release of GnRH, while the transition to burst firing with high, preovulatory levels of E2 would facilitate the GnRH surge through its glutamatergic synaptic connection to preoptic Kiss1 neurons.
